Summary of Research Advances in Oxidative Stress

Oxidative stress research has shifted from the concept of “ROS excess causing damage” toward “precise regulation of redox signaling.” ROS can damage proteins, lipids, and DNA, but they can also participate in cell fate regulation, metabolic reprogramming, immune escape, and disease progression through cysteine oxidation, transcription factor activation, non-coding RNA regulation, and epigenetic remodeling.

Keywords: oxidative stress; ROS; Nrf2; mitochondrial oxidative stress; ferroptosis; redox proteomics; non-coding RNA; precision antioxidant therapy

1 Mechanistic Framework of Oxidative Stress Research

1.1 ROS from Damage Factors to Signaling Molecules

(1) Low-level ROS

Low-level ROS participate in cellular signal transduction and can regulate protein phosphorylation, cysteine oxidation, transcription factor activity, mitochondrial function, and immune responses. Relatively stable ROS such as H₂O₂ can function as local signaling molecules and play roles in metabolic adaptation, cell proliferation, angiogenesis, and stress tolerance.

(2) High-level ROS

Sustained ROS elevation can cause lipid peroxidation, protein inactivation, DNA damage, decreased mitochondrial membrane potential, and cell death. Different forms of cell death show different degrees of ROS dependence, among which ferroptosis is most closely associated with lipid peroxidation, iron loading, and decreased GPx4 function.

(3) Redox homeostasis

Oxidative stress is not simply an increase in ROS, but an imbalance among ROS generation, clearance, localization, duration, and target modification. NADPH oxidases, the mitochondrial electron transport chain, peroxisomes, and inflammatory cells are major ROS sources. SOD, CAT, GPx, GSH, Trx, and Prx systems constitute the main antioxidant defenses.

1.2 Key Levels in Current Research

(1) Subcellular localization

ROS located near mitochondria, lysosomes, the endoplasmic reticulum, the nucleus, and the plasma membrane have different signaling consequences. Mitochondrial ROS are often associated with metabolic reprogramming, apoptosis, ferroptosis, and aging. Lysosomal oxidative stress can affect autophagic flux and metal ion homeostasis. Nuclear oxidative damage directly influences DNA repair and epigenetic status.

(2) Oxidative modification targets

Protein cysteine residues can undergo modifications such as sulfenylation, disulfide bond formation, glutathionylation, and nitrosylation. Redox proteomics enables quantitative identification of key oxidative targets, such as ACAT2, PHD2, TPβ, and VPS35, thereby linking ROS signaling to specific functional proteins.

(3) Disease-stage differences

Oxidative stress may initiate protective adaptation in early disease stages but become a factor driving tissue injury and functional decline at later stages. In tumor, neurodegenerative disease, metabolic disease, and aging models, the same antioxidant strategy may produce opposite results depending on disease stage, cell type, and tissue microenvironment.

Table 1 Research Directions and Core Questions in Oxidative Stress Studies

Research Direction	Core Question	Key Readouts
ROS-sensing mechanisms	Which proteins directly respond to ROS?	Cysteine oxidation, protein stability, complex activity
Nrf2 antioxidant pathway	How are antioxidant genes precisely activated?	Nrf2 nuclear translocation, ARE transcriptional activity, HO-1/NQO1 expression
Mitochondrial oxidative stress	How do mitochondrial ROS affect metabolism and death?	MitoSOX signal, membrane potential, ATP, oxygen consumption rate
Ferroptosis	How does lipid peroxidation trigger cell death?	GPx4, ACSL4, 4-HNE, MDA, Fe²⁺
Non-coding RNA regulation	How do circRNAs/miRNAs alter ROS homeostasis?	miRNA target genes, Nrf2/NOX4/SIRT1 axis
Epigenetic regulation	How does oxidative stress alter gene expression status?	DNA methylation, H3K4me3, antioxidant gene transcription
Disease models	Is ROS a driver or accompanying result in disease?	Tissue injury, inflammation, metabolic reprogramming, functional phenotype

2 Research Advances in Key Oxidative Stress Pathways

2.1 ROS Sensing and Protein Oxidative Modifications

(1) Oxidation of the retromer complex component VPS35

The retromer complex component VPS35 can sense ROS changes through cysteine oxidation at specific sites. Oxidation of Cys653/Cys673 in VPS35 is associated with inhibition of mitochondrial translation and can reduce mitochondrial ROS generation, allowing cancer cells to acquire antioxidant adaptation and chemoresistance. This finding suggests that ROS do not only cause damage, but can also remodel organelle function and drug response through oxidative modification.

(2) ACAT2 sulfenylation

Sulfenylation of ACAT2 at Cys277 can affect protein stability and cholesterol ester storage, helping tumor cells buffer lipotoxicity and ROS stress. This mechanism connects lipid metabolism, oxidative modification, and tumor adaptation, and is suitable for studying crosstalk between metabolic reprogramming and oxidative stress tolerance.

(3) PHD2 oxidation and HIF-1α stabilization

ROS can oxidize key cysteine residues in PHD2 and inhibit its hydroxylase activity, resulting in HIF-1α stabilization under hypoxic or normoxic oxidative stress conditions. Upregulated HIF-1α promotes glycolysis, angiogenesis, and hypoxic adaptation, making it an important node in tumor, ischemic injury, and metabolic reprogramming research.

2.2 Keap1-Nrf2-ARE Antioxidant Pathway

(1) Keap1 oxidative sensing

Keap1 senses oxidative or electrophilic stress through cysteine residues and releases Nrf2 from ubiquitin-mediated degradation. Nrf2 then enters the nucleus and activates ARE-dependent antioxidant genes. HO-1, NQO1, GCLC, GCLM, SOD, and GPx are commonly used downstream readouts.

(2) Post-translational modification of Nrf2

Nrf2 activity is regulated not only by Keap1, but also by phosphorylation, acetylation, ubiquitination, and protein interactions. Phosphorylation sites such as Ser40 can alter Nrf2 stability, nuclear translocation, and transcriptional activity, transforming the Nrf2 pathway from an “antioxidant switch” into a multilayered regulatory network.

(3) Non-coding RNA regulation

circRNAs and miRNAs can regulate the Nrf2 pathway through miRNA sponging or target silencing. Some circRNAs can activate Nrf2 through miRNA axes and reduce myocardial oxidative injury, while some miRNAs can suppress SIRT1, Nrf2, or mitochondrial function-related genes, thereby amplifying oxidative stress responses.

2.3 AMPK-SIRT1-FOXO Axis

(1) Energy stress and antioxidant transcription

Oxidative stress is often accompanied by ATP decline and AMPK activation. AMPK can promote SIRT1 activity. After SIRT1 deacetylates FOXO3, the expression of SOD, CAT, and other antioxidant enzymes is upregulated, enabling cells to acquire metabolic adaptation and antioxidant defense.

(2) Association with aging and metabolic diseases

The AMPK-SIRT1-FOXO axis is closely related to aging, insulin resistance, lipid metabolism disorders, and mitochondrial dysfunction. This axis can act as a protective mechanism against oxidative stress, but it may also fail under chronic stress, leading to reduced antioxidant capacity and accumulation of chronic inflammation.

2.4 Key Ferroptosis Axes

(1) Lipid peroxidation

Ferroptosis is driven by iron-dependent lipid peroxidation. Core readouts include decreased GPx4, GSH depletion, ACSL4 upregulation, Fe²⁺ accumulation, increased MDA, and increased 4-HNE. Unlike apoptosis, ferroptosis is more dependent on membrane lipid peroxidation and imbalance in antioxidant lipid repair systems.

(2) Parkin-ACSL4 pathway

The Parkin-ACSL4 pathway can affect the formation of lipid peroxidation substrates and ferroptosis sensitivity. ACSL4 promotes incorporation of polyunsaturated fatty acids into membrane phospholipids and is an important marker of ferroptosis-sensitive cells. Parkin-related regulation suggests crosstalk between mitochondrial quality control and lipid peroxidation.

(3) GPx4 degradation and iron overload

GPx4 degradation, GSH insufficiency, and iron overload can synergistically trigger ferroptosis. This mechanism has research value in tumor therapy, neurodegenerative disease, ischemia-reperfusion injury, and inflammatory tissue injury.

2.5 Non-Coding RNA and Epigenetic Regulation

(1) Bidirectional regulation by circRNAs

circRNAs can regulate oxidative stress by sponging miRNAs. One class of circRNAs can sponge inhibitory miRNAs and upregulate NOX4, promoting ROS generation. Another class of circRNAs can enhance antioxidant gene expression by relieving Nrf2-related inhibition. The direction of effect depends on the target miRNA and downstream pathway.

(2) miRNA networks

miR-210 can target ISCU, inhibit mitochondrial iron-sulfur cluster synthesis, and lead to mitochondrial dysfunction and increased ROS. miR-34a can silence SIRT1 and weaken FOXO- and PGC-1α-related antioxidant adaptation. miRNA networks are suitable for explaining the long-term amplification of oxidative stress.

(3) DNA methylation and histone modifications

Oxidative stress can alter DNA methylation and histone modification states. Hypermethylation of the Nrf2 promoter suppresses its expression and weakens antioxidant capacity. Activating modifications such as H3K4me3 can enhance antioxidant gene transcription. Epigenetic imbalance is an important mechanism driving persistent oxidative stress in aging and chronic diseases.

3 Oxidative Stress Mechanisms in Disease Models

3.1 Tumors

(1) Metabolic reprogramming

Tumor cells often maintain a “high ROS but non-lethal” state by altering mitochondrial function, glycolysis, lipid metabolism, and antioxidant systems. Oxidative stabilization of ACAT2, increased cholesterol ester storage, and reduced lipotoxicity help tumor cells lower oxidative pressure and adapt to rapid proliferation.

(2) Chemoresistance

VPS35 oxidation, inhibition of mitochondrial translation, and decreased ROS can allow cancer cells to reduce chemotherapy-induced oxidative pressure. This direction suggests that chemoresistance does not necessarily arise only from increased ROS-scavenging enzymes, but may also result from organelle trafficking, mitochondrial protein translation, and metabolic rearrangement.

(3) Immune escape

Tumor cells can transfer damaged mitochondria to tumor-infiltrating lymphocytes through tunneling nanotubes, inducing oxidative injury, premature senescence, and immunosuppression in T cells. Vesicle release, mitochondrial transfer, and oxidative stress together form a novel mechanism of tumor immune escape.

3.2 Neurodegenerative Diseases

(1) Early driving role

Oxidative stress is one of the early events in neurodegenerative diseases. Early ROS can initiate protective responses, whereas sustained ROS elevation promotes mitochondrial injury, protein misfolding, synaptic dysfunction, and neuroinflammation.

(2) Protein aggregation

α-Synuclein, amyloid-β, and Tau-related pathologies can mutually amplify oxidative damage. ROS promote protein oxidation and aggregation, while abnormal proteins in turn disrupt mitochondria and protein degradation systems, forming a persistent injury loop.

(3) Blood-brain barrier delivery

Low efficiency of antioxidant delivery into brain tissue is a major challenge in neurodegenerative disease intervention. Gold nanoparticles, liposomes, and mitochondria-targeted delivery systems can improve brain delivery efficiency of glutathione, natural products, or small-molecule antioxidants, making them a focus of current nano-antioxidant research.

3.3 Aging and Aging-Related Diseases

(1) Redox circadian rhythm

In young individuals, ROS and antioxidant capacity exhibit circadian fluctuations, and ROS such as H₂O₂ can show time-dependent changes. During aging, redox rhythms become disrupted. Antioxidant intervention needs to consider dosing time, tissue type, and rhythmic state, rather than simply applying long-term antioxidant supplementation.

(2) Reproductive aging

In male reproductive aging, increased sperm ROS can cause membrane lipid peroxidation, mitochondrial dysfunction, and increased DNA fragmentation index. Mitochondria-related antioxidant interventions such as coenzyme Q10 can improve sperm oxidative injury indicators in some studies, but their effects depend on baseline oxidative status and intervention duration.

(3) Mitochondrial quality control

During aging, insufficient clearance of damaged mitochondria increases ROS sources. PINK1-Parkin-mediated mitophagy, PGC-1α-mediated mitochondrial biogenesis, and the Nrf2 antioxidant pathway jointly determine whether aging cells can maintain redox homeostasis.

3.4 Cardiovascular and Metabolic Diseases

(1) Diabetic cardiomyopathy

High glucose can induce mitochondrial ROS bursts, activate inflammatory and fibrotic pathways such as MAPK/NF-κB, and promote myocardial hypertrophy, extracellular matrix deposition, and abnormal systolic and diastolic function. Studies related to SGLT2 inhibitors suggest that the AMPK-Nrf2 axis may participate in their antioxidant and cardioprotective effects.

(2) Atherosclerosis

ROS can induce endothelial dysfunction, LDL oxidation, foam cell formation, and pyroptosis, promoting plaque formation and instability. Nrf2 activators, NOX inhibitors, and mitochondrial antioxidant strategies can be used as research tools for oxidative stress in atherosclerosis.

(3) Metabolic inflammation

In obesity, insulin resistance, and fatty liver disease, ROS can connect mitochondrial dysfunction, inflammatory factor release, and lipotoxicity. In metabolic models, ROS, mitochondrial function, inflammatory factors, lipid peroxidation, and antioxidant enzyme activity should be detected together to avoid overinterpretation of a single ROS probe readout.

Table 2 Key Mechanisms in Oxidative Stress-Related Disease Models

Disease Direction	Key Mechanisms	Main Detection Indicators
Tumors	Metabolic reprogramming, chemoresistance, immune escape	ROS, ACAT2, VPS35, T-cell senescence, mitochondrial transfer
Neurodegenerative diseases	Mitochondrial injury, protein aggregation, neuroinflammation	α-syn, Aβ, Tau, MitoSOX, GSH/GSSG
Aging	Disrupted redox rhythm, reduced mitochondrial quality control	H₂O₂ rhythm, SOD/CAT, PINK1-Parkin, PGC-1α
Reproductive aging	Increased sperm ROS, DNA fragmentation	ROS, DFI, mitochondrial membrane potential, lipid peroxidation
Diabetic cardiomyopathy	High glucose–mitochondrial ROS–MAPK/NF-κB axis	ROS, NF-κB, fibrotic markers, cardiac function
Atherosclerosis	Endothelial oxidative injury, foam cells, pyroptosis	oxLDL, NLRP3, NOX, Nrf2, plaque area

4 Advances in Oxidative Stress Detection Technologies

4.1 Single-Cell Redox Omics

(1) Single-cell heterogeneity

Single-cell transcriptomics, spatial transcriptomics, and redox-related gene set analysis can resolve oxidative stress states in different cell populations. In tumors, neuroinflammation, and vascular lesions, different cell populations within the same tissue may show completely different ROS generation, antioxidant responses, and ferroptosis sensitivity.

(2) Spatial localization

Spatial omics preserves tissue structural information and connects ROS-related genes, immune cell infiltration, hypoxic regions, and pathological changes. This technology is suitable for studying local oxidative stress microenvironments in tumor margins, ischemic regions, inflammatory foci, and neurodegenerative lesions.

4.2 Subcellular Targeted ROS Probes

(1) Mitochondrial probes

MitoSOX is commonly used to detect mitochondrial superoxide and is suitable for studies of mitochondrial oxidative stress, respiratory chain injury, and ferroptosis. Experiments should control dye concentration, incubation time, mitochondrial membrane potential, and photobleaching effects to avoid misinterpreting probe accumulation differences as ROS differences.

(2) Lysosomal and other organelle probes

LysoTracker can label acidic lysosomal structures. When combined with ROS probes, it can be used to analyze lysosomal function and oxidative injury. Endoplasmic reticulum-, nucleus-, and peroxisome-targeted probes can further distinguish ROS sources and sites of action.

(3) Limitations of general ROS probes

General ROS probes such as DCFH-DA are suitable for preliminary screening but have limited specificity and are easily affected by esterase activity, metal ions, light exposure, and cellular state. Key conclusions should be validated using specific probes, antioxidant intervention, oxidative damage indicators, and functional readouts.

4.3 Redox Proteomics

(1) Quantification of cysteine oxidation

Redox proteomics can quantify modifications such as cysteine sulfenylation, disulfide bonds, and glutathionylation, making it suitable for identifying direct ROS targets. This method advances research from “ROS elevation” to “which protein is oxidized, which site is modified, and how function is altered.”

(2) Functional target validation

Candidate oxidative targets require validation through mutant constructs, protein stability assays, enzyme activity assays, cellular functional experiments, and disease models. Studies of ACAT2, PHD2, VPS35, and other targets demonstrate that oxidative modification sites themselves can serve as entry points for mechanistic research and drug intervention.

4.4 Epigenetic and Non-Coding RNA Detection

(1) DNA methylation and histone modifications

Promoter methylation and histone modifications of antioxidant genes such as Nrf2, SOD, CAT, and GPx can be detected by methylation sequencing, ChIP-qPCR, or ChIP-seq. This direction is suitable for explaining long-term silencing or abnormal activation of antioxidant genes during chronic oxidative stress.

(2) circRNA/miRNA networks

circRNA sequencing, miRNA sequencing, dual-luciferase reporter assays, RNA pull-down, and RIP can be used to validate non-coding RNA regulatory axes. Research on oxidative stress-related non-coding RNAs should simultaneously detect ROS levels, target gene expression, and functional outcomes, rather than remaining at the level of expression correlation.

Table 3 Oxidative Stress Detection Technologies and Applicable Scenarios

Technical Direction	Applicable Question	Key Considerations
General ROS probes such as DCFH-DA	Preliminary screening of total ROS	Limited specificity; functional validation required
MitoSOX	Mitochondrial superoxide	Affected by membrane potential and dye accumulation
Lipid peroxidation detection	Ferroptosis and membrane lipid injury	Can be combined with MDA, 4-HNE, and BODIPY-C11
GSH/GSSG detection	Antioxidant buffering capacity	Sample handling must prevent oxidation
Single-cell/spatial omics	Cellular heterogeneity and tissue localization	Should be combined with protein and functional readouts
Redox proteomics	Identification of direct oxidative targets	Site-directed mutation and functional validation required
ChIP/methylation detection	Epigenetic regulation of antioxidant genes	Distinguish causality from accompanying changes
circRNA/miRNA detection	Non-coding RNA regulatory axes	Target gene and functional validation required

5 Research Advances in Oxidative Stress Intervention Strategies

5.1 Precision Antioxidant Intervention

(1) From indiscriminate ROS scavenging to redox-state regulation

Traditional antioxidant strategies emphasize ROS scavenging, but excessive ROS removal may suppress normal signal transduction, immune killing, and adaptive stress responses. Precision antioxidant intervention emphasizes regulating ROS levels in specific tissues, time windows, and disease stages, rather than continuously and systemically reducing ROS.

(2) Time-sequenced intervention

Redox circadian rhythms suggest that antioxidant intervention should consider the biological clock. In aging and metabolic diseases, ROS peaks, antioxidant enzyme activity, and drug responses may all differ over time. Future intervention strategies need to integrate dosing time and tissue rhythmic status.

5.2 Mitochondria-Targeted Antioxidant Intervention

(1) MitoQ and SS-31

Mitochondria-targeted antioxidants such as MitoQ and SS-31 can accumulate in mitochondria, reduce mitochondrial ROS, and improve membrane potential and respiratory chain function. This strategy has research value in aging, neurodegenerative diseases, ischemia-reperfusion injury, and metabolic disease models.

(2) Mitochondrial quality control

ROS scavenging alone is insufficient to restore mitochondrial homeostasis. PINK1-Parkin-mediated mitophagy, PGC-1α-mediated mitochondrial biogenesis, and regulation of fusion/fission dynamics should be evaluated together with mitochondrial antioxidant strategies.

5.3 Exercise Regulation of Oxidative Stress

(1) Endurance exercise

Endurance exercise can activate mitochondrial adaptation through moderate ROS stimulation, promoting PINK1-Parkin-mediated mitophagy, PGC-1α-mediated mitochondrial biogenesis, and antioxidant enzyme expression. Exercise-induced ROS represent a typical form of low-dose adaptive stress.

(2) Experimental design

Exercise intervention models should record exercise intensity, duration, sampling time, training cycle, and tissue type. Excessive exercise may cause oxidative damage, whereas moderate exercise can enhance antioxidant capacity. These two conditions should not be conflated in result interpretation.

5.4 Natural Products and Nanodelivery

(1) Natural products

Natural products such as resveratrol, curcumin, and ergothioneine can exert antioxidant effects by activating Nrf2, inhibiting NOX, regulating mitochondrial function, or reducing lipid peroxidation. Their main limitations are poor solubility, low bioavailability, insufficient targeting, and complex multi-target effects.

(2) Nanodelivery

Nanocarriers can improve antioxidant stability, tissue targeting, and cross-barrier delivery. Gold nanoparticles, liposomes, and mitochondria-targeted nanosystems can be used for delivery to brain tissue, tumor microenvironments, and inflammatory tissues, but oxidative stress and immune responses caused by the carrier itself should be evaluated simultaneously.

Table 4 Oxidative Stress Intervention Strategies and Research Focus

Intervention Strategy	Main Action	Applicable Research Directions	Considerations
Nrf2 activators	Upregulate antioxidant genes	Inflammation, metabolic disease, cardiovascular injury	Long-term activation may affect tumor adaptation
NOX inhibitors	Reduce enzyme-derived ROS	Vascular injury, inflammation, fibrosis	NOX isoforms must be distinguished
MitoQ/SS-31	Target mitochondrial ROS	Aging, neurodegenerative diseases, ischemic injury	Mitochondrial function should be assessed, not only ROS
Ferroptosis inhibitors	Inhibit lipid peroxidation	Neural injury, ischemia-reperfusion, tumor research	Should be combined with GPx4, ACSL4, and Fe²⁺ readouts
Exercise intervention	Induce adaptive antioxidant responses	Aging, metabolic disease, mitochondrial function research	Intensity and sampling time affect conclusions
Natural products	Multi-target antioxidant regulation	Inflammation, metabolism, neuroprotection	Solubility and bioavailability must be controlled
Nanodelivery	Improve targeting and stability	Brain diseases, tumors, inflammatory tissues	Carrier toxicity must be evaluated

Table 5 Small Molecules, Probes, and Intervention Reagents Related to Oxidative Stress Research

Research Module	Product Name	CAS No.	Application Positioning
Oxidative stress model construction	Hydrogen peroxide	7722-84-1	Constructs acute ROS elevation and oxidative injury models
Oxidative stress model construction	tert-Butyl hydroperoxide (t-BHP)	75-91-2	Constructs stable oxidative stress models
Oxidative stress model construction	Menadione	58-27-5	Induces intracellular ROS generation and oxidative injury
Mitochondrial ROS model	Rotenone	83-79-4	Inhibits mitochondrial complex I and induces mitochondrial ROS
Total ROS detection	DCFH-DA ROS fluorescent probe	4091-99-0	Preliminary screening of total cellular ROS
Superoxide detection	Dihydroethidium (DHE)	104821-25-2	Detects intracellular superoxide
Lipid peroxidation detection	BODIPY 581/591 C11 lipid peroxidation probe	217075-36-0	Detects membrane lipid peroxidation and ferroptosis-related lipid ROS
Mitochondrial membrane potential detection	JC-1 mitochondrial membrane potential detection reagent	3520-43-2	Evaluates changes in mitochondrial membrane potential
Lipid oxidative damage	4-Hydroxynonenal (4-HNE)	75899-68-2	Marker of lipid peroxidation damage
DNA oxidative damage	8-Hydroxydeoxyguanosine (8-OHdG)	88847-89-6	DNA oxidative damage standard or detection control
Glutathione system	Reduced glutathione (GSH)	70-18-8	Antioxidant buffering system research and standard
Glutathione system	Oxidized glutathione (GSSG)	27025-41-8	Analysis of GSH/GSSG redox status
GSH depletion model	L-Buthionine sulfoximine (BSO)	83730-53-4	Inhibits GSH synthesis and constructs reduced antioxidant capacity models
Nrf2 pathway activation	Sulforaphane	4478-93-7	Positive intervention for Nrf2 pathway activation
Nrf2 pathway activation	tert-Butylhydroquinone (tBHQ)	1948-33-0	Nrf2/ARE pathway activation research
Nrf2 pathway activation	Oltipraz	64224-21-1	Nrf2 agonist commonly used in antioxidant pathway research
NOX-related ROS	Apocynin	498-02-2	Research on NADPH oxidase-related ROS
NOX-related ROS	Diphenyleneiodonium chloride (DPI)	4673-26-1	NOX/flavoenzyme-related ROS inhibition research
Ferroptosis induction	Erastin	571203-78-6	Induces GSH depletion and ferroptosis
Ferroptosis induction	RSL3	1219810-16-8	Inhibits GPx4 and induces lipid peroxidation and ferroptosis
Ferroptosis inhibition	Ferrostatin-1	347174-05-4	Ferroptosis rescue experiments and mechanistic validation
Ferroptosis inhibition	Liproxstatin-1	950455-15-9	Inhibits lipid peroxidation and validates ferroptosis
Iron chelation intervention	Deferoxamine mesylate	138-14-7	Iron chelation and ferroptosis inhibition experiments
General antioxidant intervention	N-Acetyl-L-cysteine (NAC)	616-91-1	ROS scavenging and GSH precursor supplementation
General antioxidant intervention	Trolox	53188-07-1	Water-soluble vitamin E analogue and antioxidant positive control
General antioxidant intervention	Coenzyme Q10	303-98-0	Mitochondrial electron transport and antioxidant research
General antioxidant intervention	Melatonin	73-31-4	ROS scavenging and mitochondrial protection research
Natural product antioxidant	Resveratrol	501-36-0	SIRT1/Nrf2-related antioxidant research
Natural product antioxidant	Curcumin	458-37-7	Nrf2 activation, NOX inhibition, and inflammation regulation
Natural product antioxidant	Ergothioneine	497-30-3	Natural antioxidant and cytoprotection research
Redox proteomics	N-Ethylmaleimide (NEM)	128-53-0	Blocks free thiols for cysteine oxidative modification research
Redox proteomics	Iodoacetamide (IAA)	144-48-9	Thiol alkylation and sample processing for protein oxidative modification

6 Common Experimental Questions and Result Interpretation

6.1 Does ROS elevation necessarily indicate oxidative damage?

Not necessarily. Short-term, local, low-level ROS can act as signaling molecules and participate in adaptive responses. Sustained, high-level ROS that spread across organelles are more likely to cause oxidative damage. Experiments should integrate lipid peroxidation, protein oxidation, DNA damage, mitochondrial function, and cell fate indicators for comprehensive interpretation.

6.2 Is DCFH-DA detection sufficient for ROS analysis?

No. DCFH-DA is suitable for preliminary screening of total ROS, but its specificity is limited and it is easily affected by cellular esterase activity, light exposure, metal ions, and cellular state. Key conclusions should be validated using MitoSOX, BODIPY-C11, GSH/GSSG, MDA, 4-HNE, or redox proteomics.

6.3 How can mitochondrial ROS be distinguished from NOX-derived ROS?

Subcellular probes, mitochondrial respiratory function assays, NOX inhibitors, mitochondria-targeted antioxidants, and genetic interventions can be combined. If MitoSOX elevation is accompanied by decreased membrane potential, abnormal oxygen consumption, and ATP reduction, a mitochondrial source is more strongly supported. If NOX4 is upregulated and can be reversed by NOX inhibitors, this supports the contribution of enzyme-derived ROS.

6.4 Does increased Nrf2 necessarily indicate enhanced protection?

Not necessarily. Increased Nrf2 may indicate antioxidant protection, but it may also suggest that cells are under sustained oxidative pressure. In tumors, sustained Nrf2 activation may also promote survival, drug resistance, and metabolic adaptation. Result interpretation should integrate ROS levels, downstream antioxidant genes, cellular function, and disease context.

6.5 Is ROS detection alone reliable in ferroptosis experiments?

No. Ferroptosis should be evaluated by detecting lipid peroxidation, GPx4, ACSL4, GSH, Fe²⁺, MDA/4-HNE, and validated through ferroptosis inhibitors or key gene interventions. General ROS elevation is not equivalent to ferroptosis.

6.6 How should ineffective antioxidant intervention be analyzed?

It should first be examined whether the drug reaches the target tissue or organelle, whether the concentration covers the effective window, whether the dosing time matches the oxidative stress stage, whether ROS are a driving factor in the model, whether the detection probe is reliable, and whether the antioxidant itself affects metabolic or immune readouts.

The core of oxidative stress research is shifting from “detecting whether ROS are elevated” to “localizing ROS sources, identifying oxidative targets, explaining pathway reprogramming, and establishing precision intervention strategies.” In research experiments, only by integrating ROS detection, molecular mechanisms, disease models, and functional endpoints can the true role of oxidative stress in disease progression and intervention responses be accurately determined.

For more related articles, please see below:

[1] Mechanisms by Which Flavonoid Natural Products Regulate the Oxidative Stress-Inflammation Axis

[2] Role of Nitric Oxide Synthase in NO Production, Inflammatory Regulation, and Oxidative Stress Research

[3] Metabolism and Oxidative Stress Detoxification, and Its Detection Applications

[4] Oxidative Stress and Experimental Interpretation Framework for ROS, JC-1, MPTP, and Calcium Indicators in Mitochondrial Function Assessment

[5] Roles of One-Carbon Metabolism Enzymes in Oxidative Stress and Epigenetic Regulation in Cardiovascular Diseases